PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 105 filers reported holding PULMONX CORP in Q3 2022. The put-call ratio across all filers is 2.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,265,898 | -30.6% | 2,929,903 | -11.9% | 0.09% | -32.3% |
| Q2 2023 | $43,604,712 | +26.5% | 3,326,065 | +7.9% | 0.13% | +21.5% |
| Q1 2023 | $34,470,735 | +131.9% | 3,083,250 | +74.9% | 0.11% | +109.8% |
| Q4 2022 | $14,865,108 | +69.4% | 1,763,358 | +234.7% | 0.05% | +45.7% |
| Q3 2022 | $8,776,000 | +51.5% | 526,797 | +33.8% | 0.04% | +45.8% |
| Q2 2022 | $5,794,000 | +236.5% | 393,600 | +467.1% | 0.02% | +242.9% |
| Q1 2022 | $1,722,000 | -83.1% | 69,400 | -78.2% | 0.01% | -82.9% |
| Q4 2021 | $10,195,000 | +12.8% | 317,907 | +26.6% | 0.04% | +2.5% |
| Q3 2021 | $9,038,000 | -69.0% | 251,200 | -62.0% | 0.04% | -69.5% |
| Q2 2021 | $29,155,000 | +95.3% | 660,801 | +102.5% | 0.13% | +87.1% |
| Q1 2021 | $14,926,000 | +165.0% | 326,313 | +299.9% | 0.07% | +159.3% |
| Q4 2020 | $5,632,000 | – | 81,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 815,019 | $37,279,000 | 40.66% |
| Yu Fan | 303,030 | $13,861,000 | 36.18% |
| ABG Innovation Capital Partners III GP Ltd | 833,333 | $38,117,000 | 18.73% |
| KPCB XIII Associates, LLC | 994,971 | $45,510,000 | 9.36% |
| Iron Triangle Partners LP | 600,000 | $27,444,000 | 3.49% |
| Miura Global Management | 405,000 | $18,525,000 | 3.31% |
| GREAT POINT PARTNERS LLC | 114,345 | $5,230,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 937,032 | $42,860,000 | 0.90% |
| ADAMS STREET PARTNERS LLC | 114,661 | $5,245,000 | 0.84% |
| RTW INVESTMENTS, LP | 1,129,600 | $51,668,000 | 0.81% |